IDEXX Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	4,167	3,898	3,661	3,367	3,215	2,707
Revenue Growth (YoY)	8.39%	6.46%	8.72%	4.73%	18.80%	12.45%
Cost of Revenue	1,595	1,519	1,471	1,363	1,326	1,136
Gross Profit	2,572	2,379	2,190	2,004	1,889	1,571
Selling, General & Admin	1,033	969.3	901.89	850.75	796.4	735.27
Research & Development	242.1	219.79	190.95	254.82	161.01	141.25
Operating Expenses	1,275	1,189	1,093	1,106	957.4	876.52
Operating Income	1,297	1,190	1,097	898.77	932.03	694.52
Interest Expense	-37.14	-31.21	-41.58	-39.86	-29.81	-33.13
Interest & Investment Income	4.62	12.7	5.63	1.07	0.43	0.59
EBT Excluding Unusual Items	1,265	1,171	1,061	859.97	902.65	661.99
Legal Settlements	9	-61.5	-	-	-	-
Pretax Income	1,274	1,110	1,061	859.97	902.65	661.99
Income Tax Expense	246.17	221.96	216.13	180.88	157.81	79.85
Earnings From Continuing Operations	1,027	887.87	845.04	679.09	744.84	582.13
Minority Interest in Earnings	-	-	-	-	0	-0.36
Net Income	1,027	887.87	845.04	679.09	744.85	581.78
Net Income to Common	1,027	887.87	845.04	679.09	744.85	581.78
Net Income Growth	18.61%	5.07%	24.44%	-8.83%	28.03%	36.02%
Shares Outstanding (Basic)	81	82	83	84	85	85
Shares Outstanding (Diluted)	82	83	84	85	87	87
Shares Change (YoY)	-2.45%	-0.87%	-0.73%	-2.28%	-0.17%	-0.94%
EPS (Basic)	12.70	10.77	10.17	8.12	8.74	6.82
EPS (Diluted)	12.60	10.67	10.06	8.03	8.60	6.71
EPS Growth	21.65%	6.06%	25.28%	-6.63%	28.17%	37.22%
Free Cash Flow	963.57	808.08	772.88	394.15	636	541.11
Free Cash Flow Per Share	11.82	9.71	9.20	4.66	7.35	6.24
Gross Margin	61.72%	61.04%	59.82%	59.52%	58.76%	58.04%
Operating Margin	31.13%	30.53%	29.97%	26.69%	28.99%	25.66%
Profit Margin	24.65%	22.78%	23.08%	20.17%	23.16%	21.49%
Free Cash Flow Margin	23.12%	20.73%	21.11%	11.71%	19.78%	19.99%
EBITDA	1,437	1,320	1,212	1,011	1,037	790.52
EBITDA Margin	34.49%	33.86%	33.11%	30.01%	32.24%	29.21%
D&A For EBITDA	140.17	129.94	114.91	111.9	104.6	96
EBIT	1,297	1,190	1,097	898.77	932.03	694.52
EBIT Margin	31.13%	30.53%	29.97%	26.69%	28.99%	25.66%
Effective Tax Rate	19.33%	20.00%	20.37%	21.03%	17.48%	12.06%
Revenue as Reported	4,167	3,898	3,661	3,367	3,215	2,707
Advertising Expenses	-	3.4	4.2	5	3.3	1.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.